MedTrace Logo

Validation of Neurokeeper's Algorithm on Patients Undergoing Cardiac Surgery.

NCT01737749 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2012-11-29

No results posted yet for this study

Summary

The primary objective of the study is to check the ability of Neurokeeper's algorithm system to detect and monitor changes in cerebral electrophysiological parameters as compared to clinical evaluation in patients undergoing cardiac surgery.

The secondary objectives is correlations of EEG + ERP measurements with clinical evaluations as assessed by NIHSS ThiS study is a prospective, open label, single arm, self control, single center study.

This study will be conducted in 50 subjects according to the inclusions/exclusions criteria.

Conditions

Interventions

DEVICE

Neurokeeper stroke detector

Electrophisoloigcal monitoring

Sponsors & Collaborators

  • Neurokeeper Technologies

    lead INDUSTRY

Principal Investigators

  • Moshe' Herskovitz, MD · Rambam Health Care Campus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01737749 on ClinicalTrials.gov